Pénuries de médicaments : augmenter les prix pénalisera les pays les plus pauvres

This joint op-ed, spearheaded by Pauline Londeix and Jérôme Martin of OTMeds, along with Stéphane Besançon from the NGO Santé Diabète, was published in the print edition of Libération and is also available online. It argues that increasing drug prices is not a suitable solution to the structural shortages of these products and will, in fact, have harmful effects on global access to treatment. This price hike is being advocated by pharmaceutical companies and supported by many political leaders.